{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:14:58Z","timestamp":1787537698422,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hangzhou Health Science and Technology Plan","award":["A20220018"],"award-info":[{"award-number":["A20220018"]}]},{"name":"Hangzhou Health Science and Technology Plan","award":["ZD2022005"],"award-info":[{"award-number":["ZD2022005"]}]},{"name":"Key project joint construction by Science and Technology Department of National Administration of TCM and Zhejiang Administration of TCM","award":["GZY-ZJ-KJ-23088"],"award-info":[{"award-number":["GZY-ZJ-KJ-23088"]}]},{"name":"Key project joint construction by Science and Technology Department of National Administration of TCM and Zhejiang Administration of TCM","award":["GZY-ZJ-KJ-24055"],"award-info":[{"award-number":["GZY-ZJ-KJ-24055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02759-x","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:05:37Z","timestamp":1746767137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibitory effect of Alantolactone against varicella-zoster virus in vitro"],"prefix":"10.1186","volume":"22","author":[{"given":"Xinna","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genxiang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2759_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0147-9571(91)90123-U","volume":"14","author":"R Manservigi","year":"1991","unstructured":"Manservigi R, Cassai E. The glycoproteins of the human herpesviruses. Comp Immunol Microbiol Infect Dis. 1991;14:81\u201395.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"2759_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","volume":"19","author":"SA Connolly","year":"2021","unstructured":"Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol. 2021;19:110\u201321.","journal-title":"Nat Rev Microbiol"},{"key":"2759_CR3","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, et al. Varicella Zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.","journal-title":"Nat Rev Dis Primers"},{"key":"2759_CR4","unstructured":"Abendroth AMAA. Varicella-Zoster virus. In Fields Virology. Edited by Howley DMKaPM: Lippincott Williams & Wilkins; 2021."},{"key":"2759_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella Zoster virus pathogenesis. Nat Rev Microbiol. 2014;12:197\u2013210.","journal-title":"Nat Rev Microbiol"},{"key":"2759_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","volume":"130","author":"JI Cohen","year":"1999","unstructured":"Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. 1999;130:922\u201332.","journal-title":"Ann Intern Med"},{"key":"2759_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3892\/mmr.2013.1824","volume":"9","author":"KP To","year":"2014","unstructured":"To KP, Kang SC, Song YJ. The extract of Elaeocarpus sylvestris inhibits human cytomegalovirus immediate early gene expression and replication in vitro. Mol Med Rep. 2014;9:744\u20138.","journal-title":"Mol Med Rep"},{"key":"2759_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13365-016-0480-1","volume":"23","author":"RJ Cohrs","year":"2017","unstructured":"Cohrs RJ, Badani H, Baird NL, White TM, Sanford B, Gilden D. Induction of varicella Zoster virus DNA replication in dissociated human trigeminal ganglia. J Neurovirol. 2017;23:152\u20137.","journal-title":"J Neurovirol"},{"key":"2759_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635\u201345.","journal-title":"N Engl J Med"},{"key":"2759_CR10","first-page":"55","volume":"18","author":"GE Gross","year":"2020","unstructured":"Gross GE, Eisert L, Doerr HW, Fickenscher H, Knuf M, Maier P, Maschke M, M\u00fcller R, Pleyer U, Sch\u00e4fer M, et al. S2k guidelines for the diagnosis and treatment of herpes Zoster and postherpetic neuralgia. J Dtsch Dermatol Ges. 2020;18:55\u201378.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2759_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes Zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.","journal-title":"BMC Infect Dis"},{"key":"2759_CR12","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes Zoster: towards a global perspective. BMJ Open. 2014;4:e004833.","journal-title":"BMJ Open"},{"key":"2759_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.antiviral.2009.07.010","volume":"84","author":"P Sasivimolphan","year":"2009","unstructured":"Sasivimolphan P, Lipipun V, Likhitwitayawuid K, Takemoto M, Pramyothin P, Hattori M, Shiraki K. Inhibitory activity of Oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro. Antiviral Res. 2009;84:95\u20137.","journal-title":"Antiviral Res"},{"key":"2759_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.antiviral.2006.07.004","volume":"72","author":"JJ Docherty","year":"2006","unstructured":"Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T. Resveratrol Inhibition of varicella-zoster virus replication in vitro. Antiviral Res. 2006;72:171\u20137.","journal-title":"Antiviral Res"},{"key":"2759_CR15","unstructured":"Gnann JW Jr. Antiviral therapy of varicella-zoster virus infections. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Edited by Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K. Cambridge: Cambridge University Press Copyright \u00a9 Cambridge University Press; 2007."},{"key":"2759_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0166-3542(98)00057-6","volume":"40","author":"M Ida","year":"1999","unstructured":"Ida M, Kageyama S, Sato H, Kamiyama T, Yamamura J, Kurokawa M, Morohashi M, Shiraki K. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants. Antiviral Res. 1999;40:155\u201366.","journal-title":"Antiviral Res"},{"key":"2759_CR17","doi-asserted-by":"publisher","first-page":"17193","DOI":"10.3390\/ijms140817193","volume":"14","author":"B Bao","year":"2013","unstructured":"Bao B, Meng Z, Li N, Meng Z, Zhang L, Cao Y, Yao W, Shan M, Ding A. Design, synthesis and antiviral activity studies of schizonepetin derivatives. Int J Mol Sci. 2013;14:17193\u2013203.","journal-title":"Int J Mol Sci"},{"key":"2759_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.antiviral.2017.06.018","volume":"144","author":"S Bae","year":"2017","unstructured":"Bae S, Kim SY, Do MH, Lee CH, Song YJ. 1,2,3,4,6-Penta-O-galloyl-\u00df-D-glucose, a bioactive compound in Elaeocarpus sylvestris extract, inhibits varicella-zoster virus replication. Antiviral Res. 2017;144:266\u201372.","journal-title":"Antiviral Res"},{"key":"2759_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12275-019-8514-z","volume":"57","author":"JE Kim","year":"2019","unstructured":"Kim JE, Song YJ. Anti-varicella-zoster virus activity of cephalotaxine esters in vitro. J Microbiol. 2019;57:74\u20139.","journal-title":"J Microbiol"},{"key":"2759_CR20","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3892\/mmr.2017.6444","volume":"15","author":"S Bae","year":"2017","unstructured":"Bae S, Song YJ. Inhibition of varicella\u2013zoster virus replication by an ethanol extract of Lysimachia mauritiana. Mol Med Rep. 2017;15:3847\u201351.","journal-title":"Mol Med Rep"},{"key":"2759_CR21","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1080\/15384101.2019.1691363","volume":"18","author":"E Abu-Galiyun","year":"2019","unstructured":"Abu-Galiyun E, Huleihel M, Levy-Ontman O. Antiviral bioactivity of renewable polysaccharides against varicella Zoster. Cell Cycle. 2019;18:3540\u20139.","journal-title":"Cell Cycle"},{"key":"2759_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12967-023-04188-2","volume":"21","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang B, Tu C, Ping Y, Chen S, Wu T, Zhao Z, Mao Y, Yang Z, Cao Z, et al. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of Alantolactone on oral squamous cell carcinoma cells. J Transl Med. 2023;21:328.","journal-title":"J Transl Med"},{"key":"2759_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/cbdd.13972","volume":"98","author":"X Liu","year":"2021","unstructured":"Liu X, Bian L, Duan X, Zhuang X, Sui Y, Yang L. Alantolactone: A sesquiterpene lactone with diverse Pharmacological effects. Chem Biol Drug Des. 2021;98:1131\u201345.","journal-title":"Chem Biol Drug Des"},{"key":"2759_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.intimp.2017.05.037","volume":"49","author":"M Kim","year":"2017","unstructured":"Kim M, Song K, Kim YS. Alantolactone improves palmitate-induced glucose intolerance and inflammation in both lean and obese States in vitro: adipocyte and adipocyte-macrophage co-culture system. Int Immunopharmacol. 2017;49:187\u201394.","journal-title":"Int Immunopharmacol"},{"key":"2759_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3389\/fphar.2020.01339","volume":"11","author":"B Gierlikowska","year":"2020","unstructured":"Gierlikowska B, Gierlikowski W, Demkow U. Alantolactone enhances the phagocytic properties of human macrophages and modulates their Proinflammatory functions. Front Pharmacol. 2020;11:1339.","journal-title":"Front Pharmacol"},{"key":"2759_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.14348\/molcells.2015.0062","volume":"38","author":"HS Lim","year":"2015","unstructured":"Lim HS, Ha H, Shin HK, Jeong SJ. The Genome-Wide expression profile of Saussurea Lappa extract on house dust Mite-Induced atopic dermatitis in Nc\/Nga mice. Mol Cells. 2015;38:765\u201372.","journal-title":"Mol Cells"},{"key":"2759_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/08923973.2020.1725039","volume":"42","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Ling Y, Wang X. Alantolactone mitigates renal injury induced by diabetes via Inhibition of high glucose-mediated inflammatory response and macrophage infiltration. Immunopharmacol Immunotoxicol. 2020;42:84\u201392.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2759_CR28","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1080\/14786419.2018.1543676","volume":"34","author":"YY Yan","year":"2020","unstructured":"Yan YY, Zhang Q, Zhang B, Yang B, Lin NM. Active ingredients of Inula helenium L. exhibits similar anti-cancer effects as isoalantolactone in pancreatic cancer cells. Nat Prod Res. 2020;34:2539\u201344.","journal-title":"Nat Prod Res"},{"key":"2759_CR29","first-page":"1026","volume":"44","author":"J Wang","year":"2019","unstructured":"Wang J, Zhang Y, Liu X, Wang J, Li B, Liu Y, Wang J. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated Endoplasmic reticulum stress and Akt\/GSK3\u03b2 pathway. Int J Mol Med. 2019;44:1026\u201338.","journal-title":"Int J Mol Med"},{"key":"2759_CR30","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1021\/acsnano.9b02875","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shen L, Li X, Song W, Liu Y, Huang L. Nanoformulated codelivery of Quercetin and Alantolactone promotes an antitumor response through synergistic Immunogenic cell death for Microsatellite-Stable colorectal Cancer. ACS Nano. 2019;13:12511\u201324.","journal-title":"ACS Nano"},{"key":"2759_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10096-011-1400-1","volume":"31","author":"Z Stojanovi\u0107-Radi\u0107","year":"2012","unstructured":"Stojanovi\u0107-Radi\u0107 Z, Comi\u0107 L, Radulovi\u0107 N, Blagojevi\u0107 P, Deni\u0107 M, Miltojevi\u0107 A, Rajkovi\u0107 J, Mihajilov-Krstev T. Antistaphylococcal activity of Inula helenium L. root essential oil: Eudesmane sesquiterpene lactones induce cell membrane damage. Eur J Clin Microbiol Infect Dis. 2012;31:1015\u201325.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2759_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jep.2014.04.010","volume":"154","author":"AM Seca","year":"2014","unstructured":"Seca AM, Grigore A, Pinto DC, Silva AM. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses. J Ethnopharmacol. 2014;154:286\u2013310.","journal-title":"J Ethnopharmacol"},{"key":"2759_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/iub.1068","volume":"64","author":"M Khan","year":"2012","unstructured":"Khan M, Yi F, Rasul A, Li T, Wang N, Gao H, Gao R, Ma T. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life. 2012;64:783\u201394.","journal-title":"IUBMB Life"},{"key":"2759_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13046-017-0563-8","volume":"36","author":"X Wang","year":"2017","unstructured":"Wang X, Yu Z, Wang C, Cheng W, Tian X, Huo X, Wang Y, Sun C, Feng L, Xing J, et al. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKK\u03b2 kinase activity and interrupting NF-\u03baB\/COX-2-mediated signaling cascades. J Exp Clin Cancer Res. 2017;36:93.","journal-title":"J Exp Clin Cancer Res"},{"key":"2759_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5582\/bst.2015.01171","volume":"9","author":"C Rezeng","year":"2015","unstructured":"Rezeng C, Yuan D, Long J, Suonan D, Yang F, Li W, Tong L, Jiumei P. Alantolactone exhibited anti-herpes simplex virus 1 (HSV-1) action in vitro. Biosci Trends. 2015;9:420\u20132.","journal-title":"Biosci Trends"},{"key":"2759_CR36","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1128\/JCM.00122-08","volume":"46","author":"J Schmidt-Chanasit","year":"2008","unstructured":"Schmidt-Chanasit J, Bleymehl K, Rabenau HF, Ulrich RG, Cinatl J Jr., Doerr HW. In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J Clin Microbiol. 2008;46:2122\u20134.","journal-title":"J Clin Microbiol"},{"key":"2759_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2014.05.027","volume":"206","author":"A Sloutskin","year":"2014","unstructured":"Sloutskin A, Goldstein RS. Laboratory Preparation of Varicella-Zoster virus: concentration of virus-containing Supernatant, use of a debris fraction and Magnetofection for consistent cell-free VZV infections. J Virol Methods. 2014;206:128\u201332.","journal-title":"J Virol Methods"},{"key":"2759_CR38","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1128\/JVI.02666-06","volume":"81","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol. 2007;81:9024\u201333.","journal-title":"J Virol"},{"key":"2759_CR39","doi-asserted-by":"crossref","unstructured":"Shakya AK, O\u2019Callaghan DJ, Kim SK. Interferon gamma inhibits Varicella-Zoster virus replication in a cell Line-Dependent manner. J Virol 2019, 93.","DOI":"10.1128\/JVI.00257-19"},{"key":"2759_CR40","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.apsb.2020.06.008","volume":"10","author":"Z Luo","year":"2020","unstructured":"Luo Z, Kuang X-P, Zhou Q-Q, Yan C-Y, Li W, Gong H-B, Kurihara H, Li W-X, Li Y-F, He R-R. Inhibitory effects of Baicalein against herpes simplex virus type 1. Acta Pharm Sinica B. 2020;10:2323\u201338.","journal-title":"Acta Pharm Sinica B"},{"key":"2759_CR41","doi-asserted-by":"publisher","first-page":"e0133622","DOI":"10.1128\/jcm.01336-22","volume":"60","author":"A Ma","year":"2022","unstructured":"Ma A, Langer J, Hanson KE, Bradley BT. Characterization of the cytopathic effects of Monkeypox virus isolated from clinical specimens and differentiation from common viral exanthems. J Clin Microbiol. 2022;60:e0133622.","journal-title":"J Clin Microbiol"},{"key":"2759_CR42","doi-asserted-by":"crossref","unstructured":"Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med 2020, 217.","DOI":"10.1084\/jem.20190347"},{"key":"2759_CR43","doi-asserted-by":"crossref","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Interleukin (IL-6) immunotherapy. Cold Spring Harb Perspect Biol 2018, 10.","DOI":"10.1101\/cshperspect.a028456"},{"key":"2759_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1365-2672.2003.02026.x","volume":"95","author":"SA Jassim","year":"2003","unstructured":"Jassim SA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. 2003;95:412\u201327.","journal-title":"J Appl Microbiol"},{"key":"2759_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12985-022-01954-4","volume":"19","author":"S Wang","year":"2022","unstructured":"Wang S, Zhou X, He X, Ma S, Sun C, Zhang J, Xu X, Jin W, Yan J, Lin P, Mao G. Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence. Virol J. 2022;19:224.","journal-title":"Virol J"},{"key":"2759_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1099\/0022-1317-43-1-15","volume":"43","author":"C Grose","year":"1979","unstructured":"Grose C, Perrotta DM, Brunell PA, Smith GC. Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol. 1979;43:15\u201327.","journal-title":"J Gen Virol"},{"key":"2759_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/bjo.81.3.189","volume":"81","author":"RS Moorthy","year":"1997","unstructured":"Moorthy RS, Weinberg DV, Teich SA, Berger BB, Minturn JT, Kumar S, Rao NA, Fowell SM, Loose IA, Jampol LM. Management of varicella Zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81:189\u201394.","journal-title":"Br J Ophthalmol"},{"key":"2759_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0166-0934(02)00250-1","volume":"107","author":"M Rahaus","year":"2003","unstructured":"Rahaus M, Desloges N, Wolff MH. Development of a multiplex RT-PCR to detect transcription of varicella-zoster virus encoded genes. J Virol Methods. 2003;107:257\u201360.","journal-title":"J Virol Methods"},{"key":"2759_CR49","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1128\/JVI.72.8.6832-6837.1998","volume":"72","author":"R Mahalingam","year":"1998","unstructured":"Mahalingam R, Lasher R, Wellish M, Cohrs RJ, Gilden DH. Localization of varicella-zoster virus gene 21 protein in virus-infected cells in culture. J Virol. 1998;72:6832\u20137.","journal-title":"J Virol"},{"key":"2759_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1128\/jvi.53.3.761-770.1985","volume":"53","author":"EA Montalvo","year":"1985","unstructured":"Montalvo EA, Parmley RT, Grose C. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol. 1985;53:761\u201370.","journal-title":"J Virol"},{"key":"2759_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0912373107","volume":"107","author":"B Berarducci","year":"2010","unstructured":"Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, Arvin AM. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proc Natl Acad Sci U S A. 2010;107:282\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2759_CR52","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/JVI.77.2.1211-1218.2003","volume":"77","author":"D Xia","year":"2003","unstructured":"Xia D, Srinivas S, Sato H, Pesnicak L, Straus SE, Cohen JI. Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J Virol. 2003;77:1211\u20138.","journal-title":"J Virol"},{"key":"2759_CR53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbrc.2003.12.096","volume":"314","author":"K Hagihara","year":"2004","unstructured":"Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with Proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314:363\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2759_CR54","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448\u201357.","journal-title":"Nat Immunol"},{"key":"2759_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122:143\u201359.","journal-title":"Clin Sci (Lond)"},{"key":"2759_CR56","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2759_CR57","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s004280000236","volume":"437","author":"E Bruder","year":"2000","unstructured":"Bruder E, Ersch J, Hebisch G, Ehrbar T, Klimkait T, Stallmach T. Fetal varicella syndrome: disruption of neural development and persistent inflammation of non-neural tissues. Virchows Arch. 2000;437:440\u20134.","journal-title":"Virchows Arch"},{"key":"2759_CR58","first-page":"1723","volume":"66","author":"S Shaikh","year":"2002","unstructured":"Shaikh S, Ta CN. Evaluation and management of herpes Zoster ophthalmicus. Am Fam Physician. 2002;66:1723\u201330.","journal-title":"Am Fam Physician"},{"key":"2759_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1631\/jzus.B0920049","volume":"10","author":"SM Zhu","year":"2009","unstructured":"Zhu SM, Liu YM, An ED, Chen QL. Influence of systemic immune and cytokine responses during the acute phase of Zoster on the development of postherpetic neuralgia. J Zhejiang Univ Sci B. 2009;10:625\u201330.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2759_CR60","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1212\/NXI.0000000000000382","volume":"4","author":"D Jones","year":"2017","unstructured":"Jones D, Neff CP, Palmer BE, Stenmark K, Nagel MA. Varicella Zoster virus-infected cerebrovascular cells produce a Proinflammatory environment. Neurol Neuroimmunol Neuroinflamm. 2017;4:e382.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2759_CR61","doi-asserted-by":"publisher","first-page":"ofy118","DOI":"10.1093\/ofid\/ofy118","volume":"5","author":"KW Jarosinski","year":"2018","unstructured":"Jarosinski KW, Carpenter JE, Buckingham EM, Jackson W, Knudtson K, Moffat JF, Kita H, Grose C. Cellular stress response to Varicella-Zoster virus infection of human skin includes highly elevated Interleukin-6 expression. Open Forum Infect Dis. 2018;5:ofy118.","journal-title":"Open Forum Infect Dis"},{"key":"2759_CR62","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/infdis\/jiz095","volume":"220","author":"AM Blackmon","year":"2019","unstructured":"Blackmon AM, Como CN, Bubak AN, Mescher T, Jones D, Nagel MA. Varicella Zoster virus alters expression of cell adhesion proteins in human perineurial cells via Interleukin 6. J Infect Dis. 2019;220:1453\u201361.","journal-title":"J Infect Dis"},{"key":"2759_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fphar.2017.00405","volume":"8","author":"M Kim","year":"2017","unstructured":"Kim M, Song K, Kim YS. Alantolactone improves prolonged exposure of Interleukin-6-Induced skeletal muscle inflammation associated glucose intolerance and insulin resistance. Front Pharmacol. 2017;8:405.","journal-title":"Front Pharmacol"},{"key":"2759_CR64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12931-020-01358-4","volume":"21","author":"X Dang","year":"2020","unstructured":"Dang X, He B, Ning Q, Liu Y, Guo J, Niu G, Chen M. Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2\/HO-1 and Inhibition of the NF-\u03baB pathways. Respir Res. 2020;21:95.","journal-title":"Respir Res"},{"key":"2759_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41387-024-00300-7","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Jiang Y, Jin L, Qian C, Zuo W, Lin J, Xie L, Jin B, Zhao Y, Huang L, Wang Y. Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease. Nutr Diabetes. 2024;14:41.","journal-title":"Nutr Diabetes"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02759-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T06:04:31Z","timestamp":1746770671000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02759-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2759"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02759-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}